Baird Downgrades Syneos Health to Neutral, Announces $43 Price Target

Benzinga · 05/11/2023 09:54
Baird analyst Eric Coldwell downgrades Syneos Health (NASDAQ:SYNH) from Outperform to Neutral and announces $43 price target.